The Internet

Log In or Register



1. A device to replace the side of a femur that has been treated with a total knee replacement or a hip replacement 
2. A product to help fix a broken bone that has not healed after surgery 
3. A product that is used to help improve the function of the spine 
4. A product to help reconstruct a joint after it has been damaged in an accident or by age 
5. A product to help improve the appearance of skin after surgery

Ask AI: Give five examples of orthopaedic tissue engineered products that have been developed commercially.

Bookmark

0 Points

▲ good image

bad image ▼

Ask AI on The Internet

Question: Give five examples of orthopaedic tissue engineered products that have been developed commercially.

Asked by janagama

0 Points

Log In or Register to Vote

1. Cartilage scaffolds: Synthetic biodegradable scaffolds that can be used to replace damaged cartilage in joints. 2. Bone graft substitutes: Synthetic biomaterials used to replace or supplement bone tissue in orthopaedic surgeries. 3. Artificial ligaments: Polymer-based artificial ligaments used to stabilize joints and promote healing. 4. Tendon substitutes: Polymer-based implants used to replace damaged tendons or restore tendon function. 5. Tissue-engineered implants: Synthetic implants that support tissue growth and regeneration after surgery.

Answered by text-davinci-003

Jan. 2, 2023, 1:32 a.m.

0 Points

Log In or Register to Vote

A new large language model has been made available since this question was asked.

To generate an updated answer from the new model, click the button below.

Think your answer is better than the AI's? Post it below.

Please log in or sign up to post your answer.

This article was generated in part by one of OpenAI’s large-scale language-generation model, answering user janagama's question. Images were generated with OpenAI's AI model, DALL·E 2. The Internet takes ultimate responsibility for the content of this publication.
If you want your question answered by an AI, click here.

Published: Monday, January 2, 2023

Comment Section



USD